2025-04-17 - Analysis Report
## Air Products and Chemicals Inc (APD) Stock Review

**0. Summary of Key Figures:**

* **Cumulative Return (APD):** 37.65%
* **Cumulative Return (VOO):** 76.08%
* **Return Difference (APD vs VOO):** -38.4%
* **Relative Divergence:** 24.8% (indicating APD's performance is in the 24.8th percentile relative to its historical performance against VOO)
* **Current Price:** $261.32
* **5-day MA:** $266.05
* **20-day MA:** $278.89
* **60-day MA:** $301.25
* **RSI:** 34.79 (suggestive of oversold conditions)
* **PPO:** -0.2973 (indicating bearish momentum)
* **MRI:** 0.4118 (Medium Risk)
* **Expected Return (vs. S&P 500, long-term):** -22.6%


**1. Performance Comparison and Company Overview:**

Air Products and Chemicals Inc. is a leading industrial gases company.  Over the analyzed period, APD significantly underperformed the S&P 500 (VOO), with a cumulative return of 37.65% compared to VOO's 76.08%, resulting in a difference of -38.4%.  The relative divergence of 24.8% suggests that while APD underperformed, this underperformance is not exceptionally unusual relative to its historical performance against the S&P 500.

The provided alpha and beta analysis shows varying performance across different periods. While some periods show positive alpha (outperformance), recent periods (2021-2025) consistently show negative CAGR and high MDD (Maximum Drawdown), alongside increasing beta, suggesting increased market sensitivity and underperformance.  The market cap has generally increased over time.


**2. Recent Price Movement:**

APD's price is currently below its 5, 20, and 60-day moving averages, indicating a bearish trend.  The recent price drop of $1.5 (from $265.3 to $261.32) further supports this.

**3. Technical Indicators and Expected Return:**

The RSI of 34.79 suggests the stock is currently in oversold territory, potentially indicating a bounce. However, the negative PPO (-0.2973) suggests bearish momentum. The recent relative divergence shows a short-term upward trend, but this is contradicted by the negative expected return. The MRI suggests a medium risk level. The significant negative expected return (-22.6%) indicates that, based on current projections, a long-term investment in APD is expected to underperform the S&P 500 significantly over the next two years or more.


**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue     |
|------------|-------|-------------|
| 2025-02-06 | 2.77  | $2.93 B     |
| 2024-08-01 | 3.13  | $2.99 B     |
| 2024-04-30 | 2.57  | $2.93 B     |
| 2024-02-05 | 2.74  | $3.00 B     |
| 2025-02-06 | 2.74  | $3.00 B     |


There seems to be an error in the data provided, as the same data point (2.74 EPS and $3.00B Revenue) is repeated for both 2024-02-05 and 2025-02-06.  Revenue appears relatively stable, while EPS shows some fluctuation.  A more comprehensive analysis requires accurate and complete data.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue    | Profit Margin |
|-------------|------------|---------------|
| 2024-12-31 | $2.93B     | 31.21%        |
| 2024-09-30 | $3.19B     | 33.98%        |
| 2024-06-30 | $2.99B     | 32.82%        |
| 2024-03-31 | $2.93B     | 32.04%        |
| 2023-12-31 | $3.00B     | 31.03%        |

Revenue fluctuates slightly around $3B, with a notable peak in Q3 2024. Profit margins remain relatively consistent, hovering around 32%.


**Capital and Profitability:**

| Quarter     | Equity      | ROE           |
|-------------|-------------|---------------|
| 2024-12-31 | $16.69B     | 3.70%         |
| 2024-09-30 | $17.04B     | 11.45%        |
| 2024-06-30 | $15.10B     | 4.61%         |
| 2024-03-31 | $14.91B     | 3.84%         |
| 2023-12-31 | $14.87B     | 4.10%         |

Equity shows some fluctuations, while ROE displays variability, with a significant spike in Q3 2024. This needs further investigation to understand the underlying drivers.


**6. Overall Analysis:**

APD currently shows a bearish trend, underperforming the S&P 500 significantly.  While some indicators suggest oversold conditions, the negative expected return, negative PPO, and the price being below its moving averages paint a pessimistic picture.  The relatively consistent revenue and profit margins are positive, but the fluctuating ROE and EPS, combined with the recent underperformance, raise concerns.  Further investigation into the causes of the recent underperformance and the high ROE in Q3 2024 is crucial before making any investment decisions.  The duplicated data points in the earnings report need clarification.  The negative long-term expected return compared to the S&P 500 suggests a cautious approach is warranted.
